Therefore, our data confirm that pH2AX (and its combination with MAP17) levels, is a marker of structural DNA damage in rectal tumors and thus may serve as a novel valuable and easily applicable predictive biomarker for rectal carcinoma. The gene discussed is PDZK1IP1; the disease is rectal carcinoma.